Washington University School of Medicine

Allison W. Willis, MD

Dr. Willis is a Neurologist and fellowship trained Movement Disorders specialist who focuses on the treatment of the following disorders: Parkinson Disease, Tourette's syndrome, Adult onset Dystonia, in addition to general adult movement disorders. She also performs chemodenervation (botulinum injection) for the following disorders: dystonia, spasticity/dystonia secondary to cerebral palsy.

In addition to maintaining a clinical practice, Dr. Willis has an active research program. Her primary focus is Neurodegenerative Epidemiology, the study of risk factors and outcomes associated with neurodegenerative diseases, such as Parkinson disease and dementia.

Medical Training

Dr. Willis attended the University Of Illinois College Of Medicine. She completed Neurology residency at Washington University School of Medicine, serving as Chief Resident in her final year. She then completed a fellowship in Movement Disorders at Washington University School of Medicine before joining the Faculty as an Assistant Professor of Neurology in 2009.

Selected Publications

1: Willis AW, Evanoff BA, Lian M, Galarza A, Wegrzyn A, Schootman M, Racette BA.
Metal Emissions and Urban Incident Parkinson Disease: A Community Health Study of
Medicare Beneficiaries by Using Geographic Information Systems. Am J Epidemiol.
2010 Oct 19. [Epub ahead of print] PubMed PMID: 20959505.

2: Willis AW, Sterling C, Racette BA. Conjugal Parkinsonism and Parkinson
disease: a case series with environmental risk factor analysis. Parkinsonism
Relat Disord. 2010 Mar;16(3):163-6. Epub 2009 Oct 8. PubMed PMID: 19818671;
PubMed Central PMCID: PMC2829360.

3: Willis AW, Crowner B, Brunstrom JE, Kissel A, Racette BA. High dose botulinum
toxin A for the treatment of lower extremity hypertonicity in children with
cerebral palsy. Dev Med Child Neurol. 2007 Nov;49(11):818-22. PubMed PMID:
17979859.

4: Wright Willis A, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and
ethnic variation in Parkinson disease: a population-based study of US Medicare
beneficiaries. Neuroepidemiology. 2010;34(3):143-51. Epub 2010 Jan 15. PubMed
PMID: 20090375; PubMed Central PMCID: PMC2865395.